The ability of VEGFR1-STAT3 signaling to induce angiogenesis and perfusion recovery in the T2D-HLI model presented a critical role of VEGFR1-STAT3 signaling to induce therapeutic angiogenesis in PAD. This evidence concerns the gene FLT1 and type 2 diabetes mellitus.